SBIR/STTR Research Award
Single Adsorber RPSA for Improved O2 Delivery
Award amount
$224,040Program and phase
SBIR · Phase IAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Pharmateck LLC
- Proposal award date
- 2016-09-15
- Contract end date
- 2019-02-28
- UEI
- Not reported
- Solicitation number
- HL14-011
- Topic code
- NHLBI
Research abstract
Project Summary and Abstract
The goal of this SBIR Phase I proposal is to build and test a prototype AC powered home
Medical Oxygen Concentrator MOC based on a novel patented and patent pending Rapid
Pressure Swing Adsorption RPSA technology MOCandapos s are the point of care POC devices
used for oxygen rehabilitation therapy for patients suffering from Chronic Obstructive Pulmonary
Disease COPD fibrosis and other lung diseases The proprietary single bed compact
miniature MOC has a concentric product storage tank and can continuously deliver to
Standard Liters Per Minute of O from compressed air The novel RPSA process is
capable of lowering the adsorbent weight by a factor of two while offering a better oxygen
recovery from air A commercial lithium exchanged zeolite LiLSX selective for nitrogen
adsorption will be used as the adsorbent for air separation in the prototype unit A pre treatment
layer of alumina desiccant will be added in the feed section of the device to capture the H O and
CO from ambient air to prevent contamination of LiLSX adsorbent thereby increasing device
life and reliability The operating conditions such as total cycle time individual step durations
and operating pressure will be optimized by conducting experiments on the prototype MOC unit
A set of operating conditions and procedures will be generated for the best optimum operation
of the final MOC device Our long term vision is to incubate this technology to the point of
maturity where it is ready for mass manufacture and can be licensed to a manufacturing
company This transformative MOC POC design has the potential to address the oxygen
therapy needs of nearly of COPD and other lung disease patients in need of a lightweight
compact and reliable oxygen supply Project narrative
Medical Oxygen Concentrators MOCs are the preferred commercially viable option for the
Point of Care POC treatment and rehabilitation of patients with COPD and other lung
disorders MOCandapos s can be used in remote locations airplanes cruise ships and military where
high purity oxygen is needed A miniature compact robust reliable MOC is needed in
the market to improve the lifestyle and comfort level of COPD patients
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY
- Head Up CPR and Aortic Occlusion to Improve Survival after Refractory Cardiac Arrest
- Free-Breathing Dynamic Cardiopulmonary Function Imaging System to use with Xenon MRI
- The Next Wave of Asthma Therapeutics
- Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications